Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tedalinab multiple-dose cardiac safety, CNS function, and pain perception study in healthy volunteers
NL-OMON34384Phase 1Active, not recruiting
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tedalinab in chronic pain (4 arms), sponsored by Glenmark Pharmaceuticals. Primary endpoints: Adverse events, Pharmacokinetics and 1 more. Started Jul 2010; status: active, not recruiting.
02
Drugs
tedalinab
03
Conditions
chronic pain
Beyond the preview
Go deeper on NL-OMON34384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34384.